col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


36 Results       Page 1

 [1] 
Bentham Science: Mini-Reviews in Medicinal Chemistry
  original article Date Title Authors   All Authors
1 [GO] 2022―May―12 An Updated and Focused Review on Heterocyclic Inhibitors for SARS-CoV and SARS-CoV-2 3CLpro Ajay Manaithiya, Ozair Alam, Shruti Mittal, Mohd. Javed Naim, Mohd. Imran, Ahmed Subeh Alshrari, et al. (+2)
2 [GO] 2022―Mar―30 The Immune Response to SARS-CoV-2: Mechanisms, Aging, Sequelae and Vaccines Carolina Espinoza, Marcelo Alarcón
3 [GO] 2022―Mar―02 Antiviral Compounds Based on Natural ASTRAGALUS POLYSACCHARIDE (APS): Researches and Foresight in the Strategies for Combating SARS-CoV-2 (COVID-19) Elahe Aleebrahim Dehkordi, Ehsan Heidari-Soureshjani, Alisam Aryan, Zahra Ganjirad, Faezeh Soveyzi, Afsaneh Hoseinsalari, et al. (+2)
4 [GO] 2022―Feb―02 SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics Shailendra Pratap Singh, Aayushi Bhatnagar, Sujeet Kumar Singh, Sanjib K. Patra, Navjot Kanwar, Abhinav Kanwal, et al. (+2)
5 [GO] 2022―Jan―28 Interleukin Receptor Antagonists and Janus Kinase Inhibitors Repurposed for Treatment of COVID-19 Nitin Tandon, Vijay Luxami, Runjhun Tandon, Kamaldeep Paul
6 [GO] 2022―Jan―13 Aptamers Against COVID-19: An Untested Opportunity Annekathrin Haberland, Johannes Müller
7 [GO] 2022―Jan―05 Thymoquinone: A Review of Pharmacological Importance, Oxidative Stress, COVID-19, and Radiotherapy Seyithan Taysi, Firas Shawqi Algburi, Zaid Mohammed, Omeed Akbar Ali, Muhammed Enes Taysi
8 [GO] 2022―Jan―05 Tuberculosis, BCG Vaccination and COVID-19: Are They Connected? Kellen Christina Malheiros Borges, Adeliane Castro da Costa, Lília Cristina de Souza Barbosa, Kaio Mota Ribeiro, Laura Raniere Borges dos Anjos, André Kipnis, Ana Paula Junqueira-Kipnis
9 [GO] 2021―Oct―28 The effect of plant metabolites on coronaviruses: A comprehensive review focusing on their IC50 values and molecular docking scores Parastou Farshi, Eda Ceren Kaya, Fataneh Hashempour-Baltork, Kianoush Khosravi-Darani
10 [GO] 2021―Aug―15 Synthetic Attempts Towards Eminent Anti-Viral Candidates of SARS-CoV Subhradip Kundu, Debayan Sarkar
11 [GO] 2021―Aug―06 The Promising Enzymes for Inhibitors Development against COVID-19 Zhi-Gang Sun, Feng-Ling Yu, Xiang-Ting Qiu, Shuang Li, Xue-Tang Li, Hai-Liang Zhu
12 [GO] 2021―Aug―06 Nature-derived hit, lead, and drug-like small molecules: Current status and future aspects against key target proteins of Coronaviruses Md. Junaid, Yeasmin Akter, Aysha Siddika, S. M. Abdul Nayeem, Afsana Nahrin, Syeda Samira Afrose, et al. (+2)
13 [GO] 2021―Jun―30 Neurological Effects of Sars-Cov-2 And Neurotoxicity of Antiviral Drugs Against Covid-19 Büşra Ünlü, Rahime Simsek, Selinay Başak Erdemli Köse, Anıl Yirün, Pinar Erkekoglu
14 [GO] 2021―Apr―23 RNA Coronaviruses’ Outbreaks: Recent Progress on the SARS-CoV-2 Pandemic Diagnostic Tests, Vaccination and Therapeutics Ghadeer A. R. Y. Suaifan, Bayan A. Alkhawaja, Aya A. M. Mohammed
15 [GO] 2021―Apr―13 A therapeutic journey of potential drugs against COVID-19 Fayaz Ali, Shahid Hussain, Yi Zhun Zhu
16 [GO] 2021―Apr―02 Effectiveness of Azithromycin as add-on Therapy in COVID-19 Management Shadma Wahab, Md Faruque Ahmad, Arshad Hussain, Shazia Usmani, Ambreen Shoaib, Wasim Ahmad
17 [GO] 2021―Mar―10 The situation of small molecules targeting key proteins to combat SARS-CoV-2: Synthesis, metabolic pathway, mechanism of action, and potential therapeutic applications Farzaneh Sorouri, Zahra Emamgholipour, Maryam Keykhaee, Alireza Najafi, Loghman Firoozpour, Omid Sabzevari, et al. (+3)
18 [GO] 2021―Feb―26 Elucidating the drug repurposing spectra of COVID-19 with its analogues SARS and MERS Jayanti Mishra, Chakrawarti Prasun, P.K. Sahoo, Maya S Nair
19 [GO] 2021―Feb―25 Treatment approaches for COVID-19: A critical review Nalini Sodum, Gautam Kumar, Vanishree Rao, Nitesh Kumar, Chamallamudi Mallikarjuna Rao
20 [GO] 2021―Feb―18 A review on Remdesivir: A broad-spectrum antiviral molecule for possible COVID-19 treatment Jabeena Khazir, Tariq Maqbool, Bilal Ahmad Mir
21 [GO] 2021―Feb―12 S.A.R.S Covid-19 A Medicinal Chemistry Approach Gautam Bhardwaj, Rajiv Kumar Tonk, Harish Garg, Vijay Bhalla
22 [GO] 2021―Feb―11 Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19) Habeb Al-Kamel, Oliver Grundmann
23 [GO] 2021―Feb―04 Natural substances and semisynthetic derivatives as potential alternative products against SARS-CoV-2 Virginia Fuochi, Pio Maria Furneri
24 [GO] 2021―Jan―26 Coronavirus (COVID -19): Chemical entities of biological interest Aman Mahajan, Princy Gupta
25 [GO] 2021―Jan―05 A mini review on emerging targets and Approaches for the synthesis of Anti-Viral compounds: In perspective to COVID-19 Maheswara Rao Gokada, Visweswara Rao Pasupuleti, Hari Babu Bollikolla
26 [GO] 2020―Dec―29 Drug discovery of small molecules for the treatment of COVID-19: A review on clinical studies Bharat Goel, Nivedita Bhardwaj, Nancy Tripathi, Shreyans K. Jain
27 [GO] 2020―Dec―23 Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials Subha Sankar Paul, Goutam Biswas
28 [GO] 2020―Dec―18 A short review on important drugs under clinical trial against Covid-19 Namita Misra
29 [GO] 2020―Dec―05 Synthetic and semi-synthetic drugs as promising therapeutic option for the treatment of COVID-19 Ekta Shirbhate, Preeti Patel, Vijay K Patel, Ravichandran Veerasamy, Prabodh C Sharma, Barij N Sinha, Harish Rajak
30 [GO] 2020―Nov―25 Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak Nitin Tandon, Vijay Luxami, Runjhun Tandon, Kamaldeep Paul
31 [GO] 2020―Nov―19 Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV-2 Infection (COVID-19) Surendra Kumar Nayak
32 [GO] 2020―Nov―13 Drug Re-purposing Approach and Potential Therapeutic Strategies to Treat COVID-19 Eeda Koti Reddy, Srisravanthi Battula, Shaik Anwar, Ayyiliath M Sajith
33 [GO] 2020―Oct―28 Perspectives for the use of N-acetylcysteine as a candidate drug to treat COVID-19 Pan Luo, Yi Liu, Dong Liu, Juan Li
34 [GO] 2020―Aug―24 Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century Nitesh Sanghai, Kashfia Shafiq, Geoffrey K. Tranmer
35 [GO] 2020―Aug―08 Recent Discovery for Inhibitors Targeting in SARS-CoV-2 and Developed anti-NCP Mohd. Faheem, Vinay K. Singh
36 [GO] 2020―Aug―08 Possible Targets and Therapies of SARS-CoV-2 Infection Kasturi Sarkar, Parames C. Sil, Seyed Fazel Nabavi, Ioana Beridan Neagoe, Cosmin Andrei Cismaru, Seyed Mohammad Nabavi, Solomon Habtemariam
 [1] 

36 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.010 sec